China Shenhua Energy : ANNOUNCEMENT RESIGNATION OF PRESIDENT, APPOINTMENT OF NEW PRESIDENT AND CHANGE OF AUTHORIZED REPRESENTATIVE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 01088) ANNOUNCEMENT RESIGNATION OF PRESIDENT, APPOINTMENT OF NEW PRESIDENT AND CHANGE OF AUTHORIZED REPRESENTATIVE

The Board announces that with effect from 4 January 2017: (i) Dr. Han Jianguo has resigned as the president of the Company; (ii) Dr. Ling Wen has been appointed as the president of the Company; and (iii) Dr. Han Jianguo has ceased to act as the authorized representative of the Company upon his resignation as the president of the Company, and Dr. Ling Wen has been appointed as the authorized representative of the Company for the purpose of Rule 3.05 of the Listing Rules.

RESIGNATION OF PRESIDENT

On 4 January 2017, the board of directors (the "Board") of China Shenhua Energy Company Limited (the "Company") received the written resignation of Dr. Han Jianguo as the president of the Company. Due to adjustment of work arrangements, Dr. Han Jianguo has tendered his resignation from the position as the president of the Company to the Board. In accordance with the provisions of the Company Law of the People's Republic of China and related laws and regulations and the articles of association of the Company, the resignation of Dr. Han Jianguo as the president of the Company takes effect immediately. Upon his resignation from the position as the president of the Company, Dr. Han will continue to serve as an executive director of the third session of the Board, and as a member of the Strategy Committee and the Safety, Health and Environment Committee of the Board of the Company.

Dr. Han has confirmed that during his tenure as the president of the Company, he has no disagreement with the Board and there is no matter relating to his resignation as the president that needs to be brought to the attention of the shareholders and creditors of the Company. The Board and Dr. Han have also confirmed that there is no matter relating to Dr. Han's resignation as the president that may potentially affect the operation of the Company and its subsidiaries. The Board expresses its heartfelt gratitude to Dr. Han for his diligence and contributions during his tenure as the president of the Company.

APPOINTMENT OF NEW PRESIDENT

The Board announces that Dr. Ling Wen, the vice chairman of the Board and an executive director of the Company, has been appointed as the president of the Company for a term of three years commencing from the date of approval by the Board, and may be re-appointed upon the expiry of the term. The Board has authorised Dr. Zhang Yuzhuo, the chairman of the Board, to handle the relevant matters in relation to the appointment of the president.

The biographical details of Dr. Ling Wen are as follows:

Ling Wen, male, born in February 1963, aged 53, Chinese, is a professor and Academician of Chinese Academy of Engineering. Dr. Ling has extensive management experience in financial institutions and enterprises. He received a Ph.D. degree from Harbin Institute of Technology in 1991, and conducted postdoctoral research in macroeconomics in Shanghai Jiao Tong University from 1992 to 1994.

Dr. Ling has been the president of the Company since January 2017, the vice chairman and an executive director of the third session of the Board of the Company since August 2014, a director of Shenhua Group Corporation since April 2010, and the general manager of Shenhua Group Corporation since May 2014. Dr. Ling is also a professor and mentor for doctoral students at Renmin University of China and China University of Mining and Technology.

Previously, Dr. Ling held various positions, including the president of the Company, an executive director of the first and second sessions of the Board, the vice chairman of the second session of the Board, the deputy general manager of Shenhua Group Corporation, the chairman of Shenhua Finance Co., Ltd., the deputy general manager of the International Business Department of the Industrial and Commercial Bank of China, the deputy general manager of Industrial and Commercial Bank of China (Asia) Limited and the chairman of UB China Business Management Company Limited.

Save as disclosed above, Dr. Ling does not hold any other positions in the Company or any of its subsidiaries, has not held any directorship in other listed companies in the past three years, and does not have any relationship with any directors, senior management or substantial or controlling shareholders of the Company. As at the date of this announcement, Dr. Ling does not have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance.

Pursuant to the existing service contract between Dr. Ling and the Company and the engagement agreement to be entered into, Dr. Ling's remuneration as the vice chairman and the president will be determined by the shareholders at the annual general meeting in accordance with the articles of association of the Company, with reference to the proposal put forward by the Remuneration Committee to the Board based on its terms of reference as well as Dr. Ling's duties and responsibilities.

Save for disclosed above, there is no other information required to be disclosed pursuant to Rule 13.51(2) of the Listing Rules, and the Company is not aware of any other matters in relation to the appointment of the president that need to be brought to the attention of the shareholders of the Company.

CHANGE OF AUTHORIZED REPRESENTATIVE

Dr. Han Jianguo has ceased to act as the authorized representative of the Company upon his resignation as the president of the Company with effect from 4 January 2017. Dr. Ling Wen has been appointed as the authorized representative of the Company for the purpose of Rule 3.05 of the Listing Rules with effect from 4 January 2017.

By order of the Board

China Shenhua Energy Company Limited Huang Qing

Secretary to the Board of Directors

Beijing, 4 January 2017

As at the date of this announcement, the Board comprises Dr. Zhang Yuzhuo, Dr. Ling Wen, Dr. Han Jianguo and Dr. Li Dong as executive directors, Mr. Chen Hongsheng and Mr. Zhao Jibin as non-executive directors, and Ms. Fan Hsu Lai Tai, Mr. Gong Huazhang and Mr. Guo Peizhang as independent non-executive directors.